Amyotrophic lateral sclerosis

Publication date

2017-11-04

Authors

van Es, M.A.ISNI 0000000387560600
Hardiman, Orla
Chio, Adriano
Al-Chalabi, Ammar
Pasterkamp, R JeroenORCID 0000-0003-1631-6440ISNI 0000000115734160
Veldink, JanORCID 0000-0001-5572-9657ISNI 0000000392612911
van den Berg, LeonardISNI 0000000388137302

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Amyotrophic lateral sclerosis is characterised by the progressive loss of motor neurons in the brain and spinal cord. This neurodegenerative syndrome shares pathobiological features with frontotemporal dementia and, indeed, many patients show features of both diseases. Many different genes and pathophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find effective treatments. In this Seminar, we discuss clinical and diagnostic approaches as well as scientific advances in the research fields of genetics, disease modelling, biomarkers, and therapeutic strategies.

Keywords

Taverne, General Medicine, Journal Article, Review

Citation

van Es, M A, Hardiman, O, Chio, A, Al-Chalabi, A, Pasterkamp, R J, Veldink, J H & van den Berg, L H 2017, 'Amyotrophic lateral sclerosis', The Lancet, vol. 390, no. 10107, pp. 2084-2098. https://doi.org/10.1016/S0140-6736(17)31287-4